VolitionRX Limited (VNRX) earnings
VNRX earnings moved a median of -2.19% by the close. Quarterly and annual VNRX reports and results, each read against the price at its own news timestamp. Back to the VNRX overview →
33 measured VNRX earnings events.
Where these VNRX earnings landedvs 33 measured VNRX earnings reactions
| Middle 50% of VNRX earnings reactions | -7.39% to +2.87% |
|---|---|
| Median reaction (to close) | -2.19% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 VNRX earnings events with a measured close landed between -7.39% and +2.87%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q VOLITIONRX LTD For: Jun 30 | SEC filing · Form 10-Q | -1.61% | -13.32% | |
| VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update | Press release | -1.61% | -13.32% | |
| VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update | Press release | -5.38% | -12.57% | |
| Form 10-Q VOLITIONRX LTD For: Mar 31 | SEC filing · Form 10-Q | +2.25% | +0.00% | |
| VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update | Press release | +2.25% | +0.00% | |
| VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update | Press release | -1.78% | -8.89% | |
| Form 10-K/A VOLITIONRX LTD For: Dec 31 | SEC filing · Form 10-K | -2.28% | -7.61% | |
| Form 10-K VOLITIONRX LTD For: Dec 31 | SEC filing · Form 10-K | +0.37% | +5.15% | |
| VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update | Press release | -1.60% | +2.99% | |
| VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update | Press release | -3.35% | -2.43% | |
| Form 10-Q/A VOLITIONRX LTD For: Jun 30 | SEC filing · Form 10-Q | -2.64% | -5.13% | |
| Form 10-Q VOLITIONRX LTD For: Jun 30 | SEC filing · Form 10-Q | -2.98% | +3.72% | |
| VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Press release | -2.98% | +3.72% | |
| VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update | Press release | -1.34% | +1.18% | |
| Form 10-Q VOLITIONRX LTD For: Mar 31 | SEC filing · Form 10-Q | -2.98% | -6.54% | |
| VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Press release | -2.98% | -6.54% | |
| VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update | Press release | +6.07% | +2.87% | |
| Form 10-K VOLITIONRX LTD For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.39% | |
| VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update | Press release | — | +0.55% | |
| Form 10-Q VOLITIONRX LTD For: Sep 30 | SEC filing · Form 10-Q | +2.84% | -2.86% | |
| VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Press release | +2.84% | -2.86% | |
| VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update | Press release | +4.98% | +8.70% | |
| Form 10-Q VOLITIONRX LTD For: Jun 30 | SEC filing · Form 10-Q | -0.94% | +3.64% | |
| VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update | Press release | -0.94% | +3.64% | |
| VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update | Press release | +0.79% | +0.35% | |
| Form 10-Q VOLITIONRX LTD For: Mar 31 | SEC filing · Form 10-Q | -5.75% | -13.79% | |
| VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update | Press release | -5.75% | -13.79% | |
| VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update | Press release | +5.13% | -0.54% | |
| Form 10-K VOLITIONRX LTD For: Dec 31 | SEC filing · Form 10-K | -2.56% | -3.87% | |
| VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update | Press release | -2.35% | -9.88% | |
| Form 10-Q VOLITIONRX LTD For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.19% | |
| VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update | Press release | +0.00% | -2.19% | |
| VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update | Press release | +0.00% | +6.17% |
Keep exploring
More VNRX: analyst actions → · SEC filings → · VNRX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ARGOS THERAPEUTICS (ARGS) | 498 | -0.22% | 39% |
| BIOANALYTICAL SYSTEMS (BASI) | 498 | 0.00% | 40% |
| ANI Pharmaceuticals, Inc. (ANIP) | 496 | -0.05% | 46% |
| Immutep Limited - American Depositary Shares (IMMP) | 494 | -0.42% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.